Related Experiment Video

Updated: Mar 8, 2026

CD Spectroscopy to Study DNA-Protein Interactions
06:48

CD Spectroscopy to Study DNA-Protein Interactions

Published on: February 10, 2022

7.8K

SWI/SNF complex in cancer

Chao Lu1, C David Allis1

  • 1Laboratory of Chromatin Biology and Epigenetics, Rockefeller University, New York, New York, USA.

Nature Genetics
|February 1, 2017
PubMed

Insights

New research reveals how the SWI/SNF complex regulates genes and fights tumors. These findings offer insights into treating cancers with SWI/SNF gene mutations.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The SWI/SNF complex is crucial for chromatin remodeling.
  • Dysregulation of SWI/SNF is implicated in various cancers.
  • Understanding SWI/SNF function is key for targeted cancer therapies.

Purpose of the Study:

  • To elucidate novel mechanisms of SWI/SNF complex function.
  • To explore the role of SWI/SNF in gene expression control.
  • To investigate SWI/SNF's tumor suppressive activities.

Main Methods:

  • Analysis of gene expression patterns.
  • Biochemical assays to study complex interactions.
  • Functional studies in cancer models.

Main Results:

  • Identification of new SWI/SNF-mediated gene regulation pathways.
  • Demonstration of SWI/SNF's role in preventing tumor formation.
  • Characterization of how SWI/SNF mutations impact cellular processes.

Conclusions:

  • The SWI/SNF complex plays a vital role in maintaining genomic stability and preventing oncogenesis.
  • New therapeutic strategies targeting SWI/SNF pathways are promising for cancer treatment.
  • Further research into SWI/SNF mechanisms will accelerate precision oncology efforts.

More Related Videos

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.4K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

941

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K